Press release
Study of Global Central nervous system (CNS) biomarkers Market for their upcoming demand and growth prospects in Near Future | Market Opportunities and Forecast, 2018-2023 | Major Companies: Takeda Pharmaceutical, Merck & Co., Inc., KineMed, Inc., Pfizer
According to OMR analysis, the global CNS biomarkers market is estimated to grow at a significant CAGR during the forecast period (2018-2023). The global CNS biomarkers market is growing at a significant rate due to significant R&D in the neurological biomarkers, development in an imaging system, proteomics & genomics and rise in demand for CNS biomarker. Successful clinical trials and investment in R&D are creating huge scope in the global CNS market. The global rise in adoption of the CNS market in developed and emerging economies has also boosted the market growth considerably. CNS biomarkers as personalized medicine, disease risk assessment, diagnostic development, drug discovery, and development are widely adopted across the globe. Personalized medicines and drug discovery & development have significant contribution to the growth of the CNS market.A full report of the global CNS biomarkers market is available at https://www.omrglobal.com/industry-reports/central-nervous-system-cns-biomarkers-market/
Furthermore, the global CNS biomarkers market is segmented on the basis of application, type, and end-user. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.
Market Segmentation
1. CNS biomarker Market by application
• Drug discovery & development
• Personalized medicine
• Disease risk assessment
• Other
2. CNS Biomarker Market by Type
• Safety biomarker
• Efficacy biomarker
• Pharmacodynamic biomarker
• Predictive biomarker
• Prognostic biomarker
• Validation biomarker
3. CNS Biomarker Market by End-User
• Diagnostic centers
• Hospital
• Other
Region Covered
• North America (the US and Canada)
• Europe (United Kingdom, Germany, France, Spain, Italy, and ROE)
• Asia-Pacific (China, India, Japan, and ROAP)
• Rest of the World
Company Profiled
• Adlyfe, Inc.
• Aposense, Ltd.
• Applied Neurosolutions, Inc.
• Avacta Group PLC
• Avid Radiopharmaceuticals, Inc.
• Adx Neurosciences N.V.
• Amoneta Diagnostics SAS
• Altoida, Inc.
• Banyan Biomarkers, Inc.
• Biogen, Inc.
• Diagenic ASA
• Enzo Biochem, Inc
• Fujirebio Diagnostics, Inc. (Innogenetics)
• Genenews, Ltd.
• Iron Horse Diagnostics, Inc.
• Kinemed, Inc.
• Merck & Co., Inc.
• Metabolon, Inc.,
• Neuraltus Pharmaceuticals, Inc.
• Nextgen Sciences
• Pfizer Inc.
• Thermo Fisher Scientific, Inc.
• Takeda Pharmaceutical Co. Ltd.
For related reports please visit https://www.omrglobal.com/reports-category/biotechnology/
For more update follow LinkedIn https://www.linkedin.com/company/omr-global-research/
About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.
Contact us
Orion Market Research Pvt. Ltd.
Anurag Tiwari
Email: info@omrglobal.com
India: +91 7803040404
Global:+1 6467557667
Indore-India-452010
Web: www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Study of Global Central nervous system (CNS) biomarkers Market for their upcoming demand and growth prospects in Near Future | Market Opportunities and Forecast, 2018-2023 | Major Companies: Takeda Pharmaceutical, Merck & Co., Inc., KineMed, Inc., Pfizer here
News-ID: 1645268 • Views: …
More Releases from Orion Market Research

Aviation Connectors Market By Application Analysis, Regional Outlook, Competitiv …
The global aviation connectors market was valued at approximately USD 5.6 billion in 2024 and is projected to reach around USD 11.42 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.14% from 2025 to 2034.
Aviation Connectors Market Overview
The aviation connectors market is experiencing robust growth, driven by the increasing demand for advanced avionics systems and the expansion of both commercial and military aircraft fleets.…

Industrial Wastewater Treatment Chemicals Market Development, Industry Trends, D …
The global industrial wastewater treatment chemicals market was valued at approximately USD 19.06 billion in 2024 and is projected to reach around USD 23.6 billion by 2033, growing at a CAGR of 5.4% from 2025 to 2033.
Industrial Wastewater Treatment Chemicals Market Overview
The global industrial wastewater treatment chemicals market is witnessing significant growth driven by increasing industrialization, stringent environmental regulations, and the growing need for sustainable water management. The…

Electronic Adhesives Market Development, Industry Trends, Demand and Growth Anal …
The global Electronic Adhesives Market was valued at approximately USD 5.11 billion in 2024 and is projected to reach USD 8.52 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5.6% between 2025 and 2033.
Electronic Adhesives Market Overview
The Electronic Adhesives Market is witnessing steady growth, driven by increased adoption of miniaturized electronics, EV components, and consumer gadgets requiring robust bonding, encapsulation, and thermal management. Key…

Automotive Interior Materials Market Size Future Scope, Demands and Projected In …
The global Automotive Interior Materials Market was valued at approximately USD 62.98 billion in 2024 and is projected to reach USD 91.20 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 4.2% during the period from 2025 to 2033.
Automotive Interior Materials Market Overview
The Automotive Interior Materials Market is poised for steady expansion, propelled by rising consumer demand for luxury, comfort, and lightweight vehicle interiors. With stringent…
More Releases for CNS
CNS promotes craftsmanship of towel production in China
[https://youtu.be/oP-N73N0ey0]
China News Service (CNS) issued a press release and a promo video here on Wednesday to promote the unique craftsmanship of towel production in Gaoyang [https://youtu.be/oP-N73N0ey0] County of Chinese northern Hebei Province.
According to the CNS press release, Gaoyang is the largest hub of towel production in China, where one out of every three towels in the nation originates. More than 4200 textile enterprises are competing to flourish in this region,…
Gene Therapy in CNS Disorder Market - Unlocking the Potential of Gene Therapy: T …
Newark, New Castle, USA: The "Gene Therapy in CNS Disorder Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Gene Therapy in CNS Disorder Market: https://www.growthplusreports.com/report/gene-therapy-in-cns-disorder-market/8886
This latest report…
Central Nervous System (CNS) Therapeutic Market Central Nervous System (CNS) The …
MARKET INTRODUCTION
The central nervous system (CNS) is the control panel of the body, which is responsible for cognition, movement, senses and emotions. Central nervous system diseases, is a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries. Drugs such as analgesics, anesthetics, nervous system…
Neuro Critical Care Market Insights in terms of volume and value 2018 to 2028(Mo …
Neuro critical care is an emerging field that combines the specialties that link neurology, neurosurgery, and critical care. Just as the field has evolved from primary focus on post-operative care to elective neurosurgical patients, the focus towards the resuscitation of neurological emergency cases such as traumatic brain injury or subarachnoid hemorrhage, which remain a clinical challenge. The neuro critical care market is strongly driven by the increasing focus, awareness, and…
US CNS Disorders Drug Pipeline Insight 2014
The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. In US, the numbers of CNS disorders have increased at an alarming rate, while the available therapies were unable to meet the market requirements. There has been steady to rapid growth in the market for CNS disorder, especially over the past two decades. The market for CNS therapies is one of the…
CNS Therapeutics Market Research Report 2016
“Global CNS Therapeutics Market Research Report 2016” Order This Report by calling BigMarketResearch.com at +1-971-202-1575
Notes:
Production, means the output of CNS Therapeutics
Revenue, means the sales value of CNS Therapeutics
This report studies CNS Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Pfizer, Inc. (USA)
Johnson & Johnson (USA)
Bristol-Myers Squibb…